Skip to search formSkip to main contentSkip to account menu

Ixiaro

National Institutes of Health

Related topics

Related topics

1 relation
Japanese encephalitis virus vaccine, inactivated Prefilled Syringe [Ixiaro]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose
Background: An inactivated Vero cell culture derived Japanese encephalitis virus vaccine (IXIARO) requires a booster dose 1 year… 
2017
2017
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region
Background: Japanese encephalitis (JE) is a major public health concern in Asia and poses a small but potentially fatal threat to… 
2017
2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study
Background: Japanese encephalitis remains a serious health concern in Asian countries and has sporadically affected pediatric… 
Review
2015
Review
2015
Product review on the JE vaccine IXIARO
Japanese encephalitis virus, as the most important vaccine-preventable cause of viral encephalitis in Asia, is estimated to cause… 
2015
2015
Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®.
2012
2012
A Single Dose of Vero Cell–Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain–Derived JE Vaccines
The new Japanese encephalitis vaccine (JE-VC, Ixiaro) has replaced mouse brain–derived vaccines (JE-MB) associated with serious… 
Review
2011
Review
2011
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).
Review
2010
Review
2010
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up.
Review
2009
Review
2009
Ixiaro®: a new vaccine against Japanese encephalitis
The mosquito-borne Japanese encephalitis virus (JEV) is a major threat to human health in Asia. An estimated 50,000 cases occur… 
2009
2009
A critical appraisal of Ixiaro ® – a cell-derived inactivated vaccine for Japanese encephalitis
Correspondence: Taff Jones Director, Clinical Testing Laboratories, Medimmune, 297 North Bernardo Avenue, Mountain View, CA 94043… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)